Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01818167 · ClinicalTrials.gov registry record · NA
An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01818167 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 25 participants.
The verdict
NCT01818167, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy of Provodine™ topical cream to 10% benzoyl peroxide topical body wash for the treatment of early stage hidradenitis suppurativa.
Interventions
- DRUG 10% Benzoyl Peroxide Topical Body Wash
- DRUG Provodine Topical Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-01-05 |
| Est. Completion | 2015-01-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01818167
The ClinicalTrials.gov registry entry for NCT01818167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 10% Benzoyl Peroxide Topical Body Wash is the first listed.
NCT01818167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01818167 about?
NCT01818167 is a clinical study titled "An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.". The purpose of this study is to compare the efficacy of Provodine™ topical cream to 10% benzoyl peroxide topical body wash for the treatment of early stage hidradenitis suppurativa.
What is the current status of trial NCT01818167?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2013-01-05. Estimated completion is 2015-01-21.
What interventions are being tested in trial NCT01818167?
The interventions under investigation include: 10% Benzoyl Peroxide Topical Body Wash (DRUG), Provodine Topical Cream (DRUG).
Who is sponsoring clinical trial NCT01818167?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.